SCHEMBL16723870

SCHEMBL16723870

CC(=O)CCCCCCCC(C)=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 5/20 0.72
ALDH1A1 P00352 4/20 0.64
ACHE P22303 1/20 0.55
LMNA P02545 2/20 0.50
SLC15A2 Q16348 1/20 0.50
TSHR P16473 4/20 0.47
NFKB1 P19838 1/20 0.47
PMP22 Q01453 1/20 0.47
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
TDP1 Q9NUW8 3/20 0.44
PPARG P37231 4/20 0.43
PPARD Q03181 4/20 0.43
PPARA Q07869 4/20 0.43
GPR84 Q9NQS5 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
TLR2 O60603 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12686704 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL316713 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL14749721 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL11435600 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL3626142 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL11375880 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL2775487 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL8421741 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL21818217 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2
SCHEMBL14725979 1.00 PAOX (0.72) PAOXALDH1A1ACHELMNASLC15A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110078667-A A method of extracting huperzine 云南汉德生物技术有限公司 2019-08-02 CN claimed
CN-116396519-A Shaping film and photo-curing composition 日立化成株式会社 2023-07-07 CN disclosed
WO-2019078522-A1 CEREBLON PROTEIN DEGRADATION INDUCING COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING SAME AS ACTIVE INGREDIENT 한국화학연구원 2019-04-25 WO disclosed
US-9593197-B2 Trigger-responsive chain-shattering polymers THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-03-14 US disclosed
US-20150141453-A1 Trigger-Responsive Chain-Shattering Polymers THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2015-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141453-A1 Trigger-Responsive Chain-Shattering Polymers SGTA, FUS, EWSR1 PAOX 4387/4885ALDH1A1 4343/4885ACHE 3546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.